Disease & disorder
acute lymphoblastic leukemia
MONDO:0004967
Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Clinical trials
14 shownFitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through ExerciseNCT05025774 · 2025-03-14
RECRUITINGCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionNCT05334069 · 2022-08-18
RECRUITINGImaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HDNCT06093334 · 2023-10-17
COMPLETEDDose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor MalignanciesNCT05694364 · 2023-01-25
COMPLETEDCord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic CancersNCT04083170 · 2022-10-06
TERMINATEDThe Registry of Oncology Outcomes Associated With Testing and TreatmentNCT04028479 · 2021-05-05
COMPLETEDSARS-CoV-2 Donor-Recipient Immunity TransferNCT04666025 · 2020-09-23
COMPLETEDUmbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaNCT03096782 · 2017-10-13
COMPLETEDStudy of ProTmune for Allogeneic HCT in Adult Patients With Hematologic MalignanciesNCT02743351 · 2016-12-20
COMPLETEDCollaborative Network to Take Responsibility for Oral Anticancer TherapyNCT02861209 · 2015-11-01
UNKNOWNCD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantNCT02061800 · 2013-06-03
UNKNOWNStudy of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALLNCT00349518 · 2006-12-01
WITHDRAWNPulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old ChildrenNCT00552825 · 2005-10-01
COMPLETEDNonmyeloablative Allogeneic TransplantNCT01272817 · 2001-10-01
COMPLETEDDrugs being studied
Research locations
New YorkNew York, United States3ChicagoIllinois, United States2CincinnatiOhio, United States2ColumbusOhio, United States2DetroitMichigan, United States2DuarteCalifornia, United States2HoustonTexas, United States2MinneapolisMinnesota, United States2PortlandOregon, United States2RichmondVirginia, United States2San AntonioTexas, United States2SeattleWashington, United States2
Leading sponsors
Alliance for Clinical Trials in Oncology1Bristol-Myers Squibb1City of Hope Medical Center1Diane George1Fate Therapeutics1Fred Hutchinson Cancer Center1H. Lee Moffitt Cancer Center and Research Institute1KU Leuven1M.D. Anderson Cancer Center1Masonic Cancer Center, University of Minnesota1Scripps Health1Sheba Medical Center1Taproot Health1University of Erlangen-Nürnberg Medical School1
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.